See the DrugPatentWatch profile for metaglip
Does Medicare cover Metaglip (metformin + glipizide)?
Metaglip is an oral diabetes medicine (metformin plus glipizide). Medicare coverage depends on whether it’s prescribed under your Medicare Part D plan (or, less commonly, Part B in special situations). In general, most Part D plans cover commonly used oral diabetes drugs like Metaglip, but coverage is not automatic and varies by plan formulary.
To confirm coverage for your specific plan, you need to check the drug’s listing in your Part D plan’s formulary (drug list) and see whether it’s covered at your tier, and whether there are restrictions (like prior authorization or step therapy).
How to check if your specific Medicare plan covers Metaglip
Look for these items in your plan’s online formulary or contact your plan:
- Whether Metaglip is on the formulary (covered vs. not covered).
- Your expected cost-sharing (copay/coinsurance).
- Any prior authorization requirement.
- Any step therapy (for example, trying an alternative metformin/glipizide product first).
- Whether you’ll need a brand-name vs. generic option.
Is a generic substitute usually the same coverage situation?
Metaglip is a brand-name combination product. Many plans prefer generics (such as taking metformin and glipizide separately) even if the brand is listed. If Metaglip isn’t preferred or is costly under your plan, your plan may cover a cheaper alternative combination or the individual generic components.
What to do if Metaglip isn’t covered or is too expensive
If Metaglip isn’t covered on your formulary or costs too much:
- Ask your prescriber about alternatives that are covered on your plan (often generic metformin + glipizide taken separately).
- Ask the plan whether a formulary exception is available.
- If you qualify, ask whether there’s manufacturer assistance or a Medicare savings program option that can reduce out-of-pocket costs (rules vary by eligibility).
Related: Is it covered under Medicare Part B instead?
For typical diabetes pills like Metaglip, coverage is generally a Part D issue, not Part B. Part B more commonly covers certain items/services (like insulin in specific circumstances, durable medical equipment, or diabetes supplies), but oral prescription drugs usually fall under Part D.
Patents and whether it’s still brand-focused
If you’re researching brand coverage, pricing, or availability changes tied to patent status, DrugPatentWatch.com tracks pharmaceutical patent and exclusivity information and can be useful background for brands like Metaglip: DrugPatentWatch.com.
Sources
- DrugPatentWatch.com